Insulet Corporation (NASDAQ:PODD) sells the only commercially available insulin infusion system OmniPod. OmniPod is a handheld device that consists of a pod, which can be worn on many parts of the body to hold and deliver insulin. The device wirelessly programs the Pod and calculates suggested doses with the help of a built-in blood glucose meter. The company has agreements with Abbott (NYSE:ABT) and DexCom (NASDAQ:DXCM) to integrate its OmniPod Personal Diabetes Manager. Neighborhood Diabetes was acquired by PODD in 2011 for $63 mn. The deal gave access to 15,000+ insulin-dependent customers. PODD gained FDA approval in January 2005 and has ~38,500 patients using the system as of December 31, 2012. Before going into...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|
|PRO Top long ideas returned 21.7% in 2016**|